Examining COVID-19 vaccination coverage and acceptability among migrants in transit through Mexico during 2021-2022: Insights from shelter surveys and interviews.

Publication date: Jul 11, 2025

Mexico faced significant obstacles in achieving COVID-19 vaccination coverage for migrants, particularly irregular migrants, asylum seekers, and refugees. In other contexts, migrant vaccination coverage has been influenced by prioritization policies, identification requirements, and various sociodemographic, migratory, and health factors, though these had not been fully explored in Mexico. This study analyzed factors associated with COVID-19 vaccine coverage among migrants in transit through Mexico. From November 2021 to May 2022, a convenience sample of 2,355 migrants across six shelters was surveyed on vaccination history and acceptance, as well as sociodemographic, migration, and health characteristics. To complement the survey, semi-structured interviews with migrants and key informants explored access barriers and attitudes toward COVID-19 vaccination. Of respondents, 61. 1% reported receiving at least one COVID-19 vaccine dose, with 67. 6% vaccinated prior to arriving in Mexico. Factors associated with vaccination included education level, country of prior residence, history of COVID-19 infection (OR = [95% CI, 1. 081-1. 737]), and COVID-19 testing history (OR = [95% CI, 3. 825-5. 999]). Among unvaccinated respondents, 81. 4% expressed willingness to vaccinate, often viewing it as “protection against complications or death” and a “requirement for movement between countries. ” Among respondents, 7. 2% expressed concerns related to misinformation. Findings suggest that while many migrants were vaccinated before arrival, inconsistent ID requirements and age-based restrictions impeded coverage within Mexico. Addressing misinformation and aligning local practices with national policies could improve vaccine access for this population.

Open Access PDF

Concepts Keywords
Death Adult
Mexico COVID-19
Refugees COVID-19 Vaccines
COVID-19 Vaccines
Female
Humans
Male
Mexico
Middle Aged
SARS-CoV-2
Surveys and Questionnaires
Transients and Migrants
Vaccination
Vaccination Coverage
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease IDO history
disease MESH education level
disease IDO country
disease MESH infection
disease MESH complications
disease MESH death
pathway REACTOME Reproduction
drug DRUGBANK Methionine
disease MESH cancer
disease MESH hypertension
drug DRUGBANK Trestolone
drug DRUGBANK Etoperidone
disease MESH privacy
disease IDO site
disease IDO process
disease MESH marital status
disease MESH morbidities

Original Article

(Visited 4 times, 1 visits today)